AMARILLO, TX--(MARKET WIRE)--Jun 21, 2007 -- Amarillo Biosciences, Inc. (ABI) (OTC BB:AMAR.OB - News) today announced that Dr. Joseph Cummins, President & CEO, will be featured on Market News First (www.mn1.com). The exclusive interview with the MN1 news team is scheduled for 12:15 PM EDT on June 22. Dr. Cummins will be reviewing information about the Company’s last two news releases on June 15 and June 21. These news releases reported on an upcoming clinical trial on chronic cough and additional new clinical sites for the on-going Phase 2 study in HIV+ patients with oral warts.
